Drug Profile
ASP 6973
Alternative Names: ASP6973Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Astellas Pharma
- Class Analgesics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Back pain; Osteoarthritis
Most Recent Events
- 02 Nov 2012 Discontinued - Phase-I for Back pain in Japan (PO)
- 02 Nov 2012 Discontinued - Phase-I for Osteoarthritis in Japan (PO)
- 11 May 2012 Phase-I clinical trials in Back pain in Japan (PO)